165 related articles for article (PubMed ID: 19240243)
1. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
Jamroziak K; Szemraj Z; Grzybowska-Izydorczyk O; Szemraj J; Bieniasz M; Cebula B; Giannopoulos K; Balcerczak E; Jesionek-Kupnicka D; Kowal M; Kostyra A; Calbecka M; Wawrzyniak E; Mirowski M; Kordek R; Robak T
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):945-53. PubMed ID: 19240243
[TBL] [Abstract][Full Text] [Related]
2. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.
Dong HJ; Miao KR; Qiao C; Zhuang Y; Shen WY; Hong M; Fan L; Liu P; Xu W; Li JY
Leuk Lymphoma; 2011 Jun; 52(6):1003-9. PubMed ID: 21463115
[TBL] [Abstract][Full Text] [Related]
5. CD38 gene polymorphism and risk of chronic lymphocytic leukemia.
Abramenko IV; Bilous NI; Pleskach GV; Chumak AA; Kryachok IA; Martina ZV; Dyagil IS
Leuk Res; 2012 Oct; 36(10):1237-40. PubMed ID: 22721814
[TBL] [Abstract][Full Text] [Related]
6. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
7. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
8. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
[TBL] [Abstract][Full Text] [Related]
9. CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?
Aydin S; Rossi D; Bergui L; D'Arena G; Ferrero E; Bonello L; Omedé P; Novero D; Morabito F; Carbone A; Gaidano G; Malavasi F; Deaglio S
Blood; 2008 Jun; 111(12):5646-53. PubMed ID: 18424664
[TBL] [Abstract][Full Text] [Related]
10. IRF-3 gene polymorphisms are associated with the susceptibility to and the survival in chronic lymphocytic leukemia and could also serve as an auxiliary index.
Zhang ZX; Shen CF; Shou LH; Fang Q
Leuk Lymphoma; 2017 Mar; 58(3):646-654. PubMed ID: 27348780
[TBL] [Abstract][Full Text] [Related]
11. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
[TBL] [Abstract][Full Text] [Related]
12. Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.
Tinhofer I; Rubenzer G; Holler C; Hofstaetter E; Stoecher M; Egle A; Steurer M; Greil R
Blood; 2006 Nov; 108(9):2950-6. PubMed ID: 16825496
[TBL] [Abstract][Full Text] [Related]
13. Association of CYP1A1 T3801C (rs4646903) variant with the susceptibility and progression of B-chronic lymphocytic Leukemia (B-CLL) in the Egyptian population.
Al-Adl M; El-Said A; El-Sebaie A; Refaat S; Youssef MM
Gene; 2023 Oct; 883():147673. PubMed ID: 37506988
[TBL] [Abstract][Full Text] [Related]
14. ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population.
Karabon L; Jedynak A; Tomkiewicz A; Wolowiec D; Kielbinski M; Woszczyk D; Kuliczkowski K; Frydecka I
Folia Histochem Cytobiol; 2011; 49(1):49-54. PubMed ID: 21526489
[TBL] [Abstract][Full Text] [Related]
15. CD38 and interleukin 6 gene polymorphism in egyptians with diffuse large B-cell lymphoma (DLBCL).
Talaat RM; Abdel-Aziz AM; El-Maadawy EA; Abdel-Bary N
Immunol Invest; 2015; 44(3):265-78. PubMed ID: 25564959
[TBL] [Abstract][Full Text] [Related]
16. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
Jelinek DF; Tschumper RC; Geyer SM; Bone ND; Dewald GW; Hanson CA; Stenson MJ; Witzig TE; Tefferi A; Kay NE
Br J Haematol; 2001 Dec; 115(4):854-61. PubMed ID: 11843819
[TBL] [Abstract][Full Text] [Related]
18. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
[TBL] [Abstract][Full Text] [Related]
19. MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis.
Penna G; Allegra A; Alonci A; Aguennouz M; Garufi A; Cannavò A; Gerace D; Alibrandi A; Musolino C
Med Oncol; 2011 Dec; 28(4):1549-54. PubMed ID: 20496015
[TBL] [Abstract][Full Text] [Related]
20. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
